Abbott Laboratories Corporation

John Paul Oberdier

Thomas Barton May

Lukchiu Li

Dennis A Stephens

Edward Anthony Pec

Kathee Jantzi

Daniel H Robinson

Kent D Abrahamson

Randall M Farmer

Amy N Anderson

Haiyan Grady

Kurt J Hartmann

Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1&agr;,3&bgr;,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene.

Cosolvent formulations

The invention relates to stable compositions comprising 1&agr;, 25-dihydroxycholecalciferol, a unit dose system comprising the same in a sealed vessel, and a process for preparing them.

Low oxygen content compostions of 1&agr;, 25-dihydroxycholecalciferol

Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1.alpha.,3.beta.,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene .

Growing community of inventors

Gurnee, IL, United States of America

John Paul Oberdier